大行評級|星展:下調金蝶國際目標價至10.4港元 維持“買入”評級
星展發表報吿,維持金蝶國際“買入”評級,基於公司強勁的雲業務增長及盈利能力改善,目標價由13.4港元降至10.4港元,目標價相當於預測2024年市銷率5倍,對比早前目標價為市銷率6倍,基於考慮在宏觀不確定性下的增長動力減慢。該行預測公司雲業務今年增長20%,貢獻全年收入83%,受惠於雲轉型策略。該行亦預期雲業務經營溢利由去年上半年的負7%,改善至今年的負4%,並在明年扭虧為盈,受益於經營槓桿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.